Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP477599.RAaGIPYvfKetOzFchACVa2Jn5nLuYOj8d5-g3zK2lCxu8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP477599.RAaGIPYvfKetOzFchACVa2Jn5nLuYOj8d5-g3zK2lCxu8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP477599.RAaGIPYvfKetOzFchACVa2Jn5nLuYOj8d5-g3zK2lCxu8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP477599.RAaGIPYvfKetOzFchACVa2Jn5nLuYOj8d5-g3zK2lCxu8130_provenance.
- NP477599.RAaGIPYvfKetOzFchACVa2Jn5nLuYOj8d5-g3zK2lCxu8130_assertion description "[In conclusion, a 24-month course of treatment with 6 MU IFN-alpha2b was well tolerated by most patients, led to sustained suppression of HBV in one third, and attenuated hepatitis in 81% of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477599.RAaGIPYvfKetOzFchACVa2Jn5nLuYOj8d5-g3zK2lCxu8130_provenance.
- NP477599.RAaGIPYvfKetOzFchACVa2Jn5nLuYOj8d5-g3zK2lCxu8130_assertion evidence source_evidence_literature NP477599.RAaGIPYvfKetOzFchACVa2Jn5nLuYOj8d5-g3zK2lCxu8130_provenance.
- NP477599.RAaGIPYvfKetOzFchACVa2Jn5nLuYOj8d5-g3zK2lCxu8130_assertion SIO_000772 9398007 NP477599.RAaGIPYvfKetOzFchACVa2Jn5nLuYOj8d5-g3zK2lCxu8130_provenance.
- NP477599.RAaGIPYvfKetOzFchACVa2Jn5nLuYOj8d5-g3zK2lCxu8130_assertion wasDerivedFrom befree-20150227 NP477599.RAaGIPYvfKetOzFchACVa2Jn5nLuYOj8d5-g3zK2lCxu8130_provenance.
- NP477599.RAaGIPYvfKetOzFchACVa2Jn5nLuYOj8d5-g3zK2lCxu8130_assertion wasGeneratedBy ECO_0000203 NP477599.RAaGIPYvfKetOzFchACVa2Jn5nLuYOj8d5-g3zK2lCxu8130_provenance.
- befree-20150227 importedOn "2015-02-27" NP477599.RAaGIPYvfKetOzFchACVa2Jn5nLuYOj8d5-g3zK2lCxu8130_provenance.